Abstract:Abstract BACKGROUND AND AIMS Calcific aortic valve disease (CAVD) results from fibro-calcific degeneration of the aortic valve leaflets, causing haemodynamic disorders and major cardiovascular complications. In chronic kidney disease (CKD) patients, this pathological remodelling is more frequent, appears earlier, progresses more rapidly and leads to a mortality rate three times higher than in the general population. The uremic toxin indoxyl-sulfate (IS) is a powerful predictor of cardiovascular mortality in CKD patients and a strong promoter of aortic calcification. However, its role in aortic valve leaflets mineralization has never been studied. This work aimed to evaluate whether IS can influence the mineralization of primary human valvular interstitial cells (hVICs) cultured in vitro. METHOD Primary hVICs were isolated from aortic tricuspid valves collected from patients with CAVD undergoing valve replacement surgery at the Amiens Picardie University Hospital. The concentrations of IS used in this study were selected according to the EUTOX registry: IS normal [Isn]: 0.5 μg/mL, IS uremic [Isu]: 37 μg/mL and IS maximum [Ismax]: 233 μg/mL. Human VICs mineralization were induced by exposure to an osteogenic medium containing 2.4 mmol/L calcium and 2.5 mmol/L phosphate (pro-calcific condition) and quantified by the o-cresolphthalein complexone method. The osteogenic transition of hVICs was assessed by qRT-PCR following Bmp2 and Runx2 mRNA expression. The cells’ inflammatory potential was assessed by qRT-PCR and ELISA following IL-1β, IL-6 and TNF-α expression and secretion. Activation of NFkB pathway was studied by analysing the phosphorylation of P65 via western blot. A siRNA approach was used to determine the signaling pathway involved in the effects of IS. RESULTS In pro-calcific conditions, IS increased hVICs osteogenic transition and calcification in a concentration-dependent manner, an effect that was blocked in hVICs transfected with siRNA targeting AhR expression. Data obtained by western blot showed that the exposure to [ISu] and [ISmax] promoted P65 phosphorylation in an AhR dependent manner. Blockade of the NFкB pathway with siRNA targeting P65 inhibited IS-induced expression of Bmp2 and RunX2 as well as hVICs mineralization, suggesting that hVICs inflammation plays a key role in the procalcific effects of IS. Confirming this hypothesis, the exposure to [ISu] and [ISmax] increased the expression of IL-1β, IL-6 and TNF-α transcripts, an effect abolished by silencing AhR and P65. Interestingly, hVICs did not secrete TNF-α and produced only a very low quantity of IL-1β in response to IS. By contrast, the exposure to [ISu] and [ISmax] induced an important release of IL-6 in hVICs culture medium, which was blocked when AhR and P65 were silenced. In this model, the use of an antibody neutralizing IL-6 completely abolished IS-induced hVICs osteogenic transition and calcification. CONCLUSION Our study demonstrates that IS displays direct pro-calcific effects on primary hVICs through AhR-dependent activation of the NFkB pathway and subsequent release of IL-6. We report that the autocrine action of IL-6 is responsible for IS-induced hVICs osteogenic transition and calcification. The observation that antibodies neutralizing IL-6 can block IS pro-calcific effects might be of particular interest knowing that interventional studies evaluating the cardiovascular impact of anti-IL-6 antibodies in patients with CKD are underway.

Increased calcification by erythrophagocytosis in aortic valvular interstitial cells

Iron promotes Slc7a11-deficient valvular interstitial cell osteogenic differentiation: A possible mechanism by which ferroptosis participates in intraleaflet hemorrhage-induced calcification

Histone Deacetylase 6 Reduction Promotes Aortic Valve Calcification Via an Endoplasmic Reticulum Stress-Mediated Osteogenic Pathway.

Single cell RNA-seq analysis reveals involvement of the interferon-I pathway and cellular senescence in calcific progression of human aortic valve cells

Knockdown of Estrogen‐related Receptor Α Inhibits Valve Interstitial Cell Calcification in Vitro by Regulating Heme Oxygenase 1

Oxidative stress and valvular endothelial cells in aortic valve calcification

Role of TGF-β1 Signaling in Heart Valve Calcification Induced by Abnormal Mechanical Stimulation in a Tissue Engineering Model

Deficiency of CCAAT/enhancer-binding Protein Homologous Protein (CHOP) Prevents Diet-Induced Aortic Valve Calcification in Vivo

LPS-induced senescence of macrophages aggravates calcification and senescence of vascular smooth muscle cells via IFITM3

Biological Characteristics of Valvular Interstitial Cells in Calcific Aortic Valve Disease

Pro-osteogenic role of interleukin-22 in calcific aortic valve disease

Hypoxia-inducible factor activation promotes osteogenic transition of valve interstitial cells and accelerates aortic valve calcification in a mice model of chronic kidney disease

Rho A/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK/RUNX2 axis

Mechanism of Endoplasmic Reticulum Stress Pathway in the Osteogenic Phenotypic Transformation of Aortic Valve Interstitial Cells

Late-stage Calcific Aortic Valve Disease Within an Aortic Valve-on-a-chip Model

Crosstalk between myofibroblasts and macrophages: A regulative factor of valvular fibrosis in calcific aortic valve disease

MO759: Indoxyl-Sulfate Activation of the AhR-NFΚB Pathway Promotes IL-6 Secretion and Subsequent Osteogenic Transition and Calcification of Interstitial Cells of the Aortic Valve

Cathepsin D elevates the fibrocalcific activity in human aortic valve cells through the ERK1/2-Sox9 pathway

Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2

The Haemodynamic and Pathophysiological Mechanisms of Calcific Aortic Valve Disease

Window of opportunity for developing effective medical intervention for calcific aortic valve disease